Research Article: Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT
Abstract:
In , liver cancer stood as the third leading cause of cancer-related fatalities and the sixth most prevalent cancer globally, and hepatocellular carcinoma (HCC) accounts for approximately % of liver cancer cases., The number of new cases and deaths is expected to increase by more than % by the year . China has a heavy burden of liver cancer, with more than % of global new cases and deaths occurring in this region, and about .% of liver cancer patients are afflicted with hepatitis B virus (HBV) infection., Despite the increasing coverage of hepatitis B vaccination and a steady rise in the diagnosis and treatment rates for chronic hepatitis B in China, HCC remains a persistent challenge, primarily due to the vast number of HBV-infected individuals in the population.,
Introduction:
In , liver cancer stood as the third leading cause of cancer-related fatalities and the sixth most prevalent cancer globally, and hepatocellular carcinoma (HCC) accounts for approximately % of liver cancer cases. , The number of new cases and deaths is expected to increase by more than % by the year . China has a heavy burden of liver cancer, with more than % of global new cases and deaths occurring in this region, and about .% of liver cancer patients are afflicted with hepatitis B virus (HBV) infection. ,…
Read more